ABOS compared with ACRV: revenue, margins and what each company keeps, and the suppliers and customers both name

ABOSAcumen Pharmaceuticals, Inc.

Mkt capRevenueRevenue

ACRVAcrivon Therapeutics, Inc.

Mkt capRevenueRevenue

Compare

ABOSAcumen Pharmaceuticals, Inc.

ACRVAcrivon Therapeutics, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Supply-chain overlap

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only ABOS 5

MRKMercksupplier

HALOHalozymesupplier

—JCR Pharmaceuticalsunlistedsupplier

—Lonza Salesunlistedsupplier

1 more · ABOS chain ›

Shared 0

No shared counterparties.

Only ACRV 7

LLYEli Lilly & Company (Lilly)supplier

—Akoyaunlistedsupplier

—MD Anderson Cancer Center (MDACC)unlistedsupplier

—

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

Moffitt Cancer Center

unlistedsupplier

3 more · ACRV chain ›

ABOSAcumen Pharmaceuticals, Inc.

0.24▲+12.33%· post 0.22

Mkt cap$15.2M

ACRVAcrivon Therapeutics, Inc.

1.61▼−3.01%· post 1.61

ClosedNov 2 '26

Mkt cap$12.2M

Compare

ClosedNov 2 '26

ABOSAcumen Pharmaceuticals, Inc.

ACRVAcrivon Therapeutics, Inc.

0.24▲+12.33%post 0.22

Price

1.61▼−3.01%post 1.61

$15.2M

Mkt cap

$12.2M

ABOS0.24▲+12.33%vsACRV1.61▼−3.01%ClosedNov 2 '26